Nautilus Biotechnology, Inc. ( NAUT ), a development-stage life sciences company focused on single-molecule proteomics, on Friday announced a peer-reviewed publication in Nature Methods demonstrating ...
The same validated approach used for tau is now being applied to a-synuclein in Parkinson’s disease and to AKT1, Nautilus’ first oncology proteoform assay, supporting a roadmap toward roughly 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results